Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acutil
- Development stage
- Unknown
- Lead developer
- Angelini Pharma
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Acutil is a multi-ingredient dietary supplement developed and marketed by Angelini Pharma (formerly CSC Pharmaceuticals) to support brain function and cognitive health. The formulation typically includes omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid), Ginkgo biloba extract, phosphatidylserine, vitamin E, folic acid, and vitamin B12. It is primarily indicated for maintaining memory and mental performance, particularly in the elderly or those experiencing mild age-related cognitive decline. The mechanism involves providing essential fatty acids for neuronal membranes, improving cerebral blood flow via Ginkgo biloba, and supporting homocysteine metabolism through B-vitamins.
- Brand names
- Acutil
02
Targets
MTR (Methionine synthase)PTAFR (Platelet-activating factor receptor)PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on Acutil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acutil.